美国华盛顿州西雅图耐多药志贺菌病暴发的基因组重建与针对性干预:一项基因组监测研究
该研究回顾性分析了2017年5月1日至2022年2月28日西雅图两家医疗中心粪便标本中的171例志贺菌分离株,采用全基因组测序和药敏试验。结果显示84株(51%)为耐多药,143例有抗菌治疗数据的患者中100例(70%)接受了适当经验性治疗;基因组分析揭示了不同高风险人群中的多个克隆谱系及耐药特征,为经验性治疗和公共卫生应对提供了指导。
要点
- 171例志贺菌病中,78例(46%)为男男性行为者(MSM),88例(52%)为无家可归者(PEH)。
- 84株(51%)分离株为耐多药,但143例有治疗数据的患者中100例(70%)接受了适当经验性治疗。
- 基因组分析识别出宋内志贺菌和福氏志贺菌的多个克隆谱系,分别在不同风险人群中传播。
核心结论
- 西雅图暴发由耐多药菌株平行出现驱动,涉及国际传播网络和高风险人群间的本地传播。
- 基因组分析不仅阐明了暴发起源,还指导了检测、治疗和公共卫生应对的最佳方法。
- 快速诊断结合详细的本地流行病学知识,即使面对耐多药感染也能实现高比例适当经验性治疗。
研究设计与样本
- 回顾性研究,纳入2017年5月1日至2022年2月28日西雅图Harborview医疗中心和华盛顿大学医疗中心临床实验室粪便标本中的所有志贺菌分离株。
- 对分离株进行菌种鉴定、表型药敏试验和全基因组测序,并回顾性分析患者人口学特征和临床结局。
主要发现
- 共纳入171例志贺菌病病例,78例(46%)为男男性行为者(MSM),88例(52%)为无家可归者(PEH)。
- 84株(51%)分离株为耐多药。
- 143例有抗菌治疗数据的患者中,100例(70%)接受了适当经验性治疗。
- 系统发育基因组分析识别出福氏志贺菌和宋内志贺菌多个不同谱系的连续暴发。
- 福氏志贺菌有10个离散克隆谱系,宋内志贺菌有9个离散克隆谱系,耐药特征在不同高风险人群(MSM、PEH)中导致感染。
临床怎么用
- 基因组分析指导了检测、治疗和公共卫生应对的最佳方法。
- 快速诊断结合详细的本地流行病学知识,使得即使耐多药感染也能实现高比例适当经验性治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shigella spp have been associated with community-wide outbreaks in urban settings. We analysed a sustained shigellosis outbreak in Seattle, WA, USA, to understand its origins and mechanisms of antimicrobial resistance, define ongoing transmission patterns, and optimise strategies for treatment and infection control. METHODS: We did a retrospective study of all Shigella isolates identified from stool samples at the clinical laboratories at Harborview Medical Center and University of Washington Medical Center (Seattle, WA, USA) from May 1, 2017, to Feb 28, 2022. We characterised isolates by species identification, phenotypic susceptibility testing, and whole-genome sequencing. Demographic characteristics and clinical outcomes of the patients were retrospectively examined. FINDINGS: 171 cases of shigellosis were included. 78 (46%) patients were men who have sex with men (MSM), and 88 (52%) were people experiencing homelessness (PEH). Although 84 (51%) isolates were multidrug resistant, 100 (70%) of 143 patients with data on antimicrobial therapy received appropriate empirical therapy. Phylogenomic analysis identified sequential outbreaks of multiple distinct lineages of Shigella flexneri and Shigella sonnei. Discrete clonal lineages (ten in S flexneri and nine in S sonnei) and resistance traits were responsible for infection in different at-risk populations (ie, MSM, PEH), enabling development of effective guidelines for empirical treatment. The most prevalent lineage in Seattle was probably introduced to Washington State via international travel, with subsequent domestic transmission between at-risk groups. INTERPRETATION: An outbreak in Seattle was driven by parallel emergence of multidrug-resistant strains involving international transmission networks and domestic transmission between at-risk populations. Genomic analysis elucidated not only outbreak origin, but directed optimal approaches to testing, treatment, and public health response. Rapid diagnostics combined with detailed knowledge of local epidemiology can enable high rates of appropriate empirical therapy even in multidrug-resistant infection. FUNDING: None.
引用
- Tansarli GS, Long DR, Waalkes A, et al. Genomic reconstruction and directed interventions in a multidrug-resistant Shigellosis outbreak in Seattle, WA, USA: a genomic surveillance study. Lancet Infect Dis. 2023. PMID: 36731480. doi:10.1016/S1473-3099(22)00879-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。